See All Slides - tctmd.com

Slides

Presentation TCT 2025

TCT 1004: Cardiovascular Outcomes of PCSK9 Inhibitor Use in Percutaneous Coronary Intervention

Presenter: Grant William Reed

October 27, 2025

Presentation TCT 2025

From Policy to Practice: How Reimbursement is Shaping RDN Adoption

Presenter: Matheen A. Khuddus

October 27, 2025

Presentation TCT 2025

TCT 562: Prognostic and Procedural Impact of Coexistent Aortic Stenosis in Hypertrophic Cardiomyopathy: A Propensity-Matched Cohort Study

Presenter: Usman Akbar

October 27, 2025

Presentation TCT 2025

Optimizing Shock Escalation from Interventional Perspective

Presenter: Ramesh Mazhari

October 27, 2025

Presentation TCT 2025

Siegel THV: Case Examples

Presenter: Rahul Prakash Sharma

October 27, 2025

Presentation TCT 2025

Do We Need RCTs?

Presenter: Steven J. Yakubov

October 27, 2025

Presentation TCT 2025

TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial

Presenter: Terumitsu Hasebe

October 27, 2025

Presentation TCT 2025

SIMPLAAFYing the Post-Implant Drug Regimen

Presenter: Christine J. Chung

October 27, 2025

Presentation TCT 2025

Putting CT-Guided PCI into Practice

Presenter: Yader Sandoval

October 27, 2025

Presentation TCT 2025

TCT 940: Prognostic Role of Alpha Defensin in Predicting Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention

Presenter: Rami Abu Fanne

October 27, 2025

Advertisement

Slides

TCT 1004: Cardiovascular Outcomes of PCSK9 Inhibitor Use in Percutaneous Coronary Intervention

From Policy to Practice: How Reimbursement is Shaping RDN Adoption

TCT 562: Prognostic and Procedural Impact of Coexistent Aortic Stenosis in Hypertrophic Cardiomyopathy: A Propensity-Matched Cohort Study

Optimizing Shock Escalation from Interventional Perspective

Siegel THV: Case Examples

Do We Need RCTs?

TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial

SIMPLAAFYing the Post-Implant Drug Regimen

Putting CT-Guided PCI into Practice

TCT 940: Prognostic Role of Alpha Defensin in Predicting Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content